149 related articles for article (PubMed ID: 211448)
1. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
Biggio G; Corda MG; Casu M; Gessa GL
Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
[TBL] [Abstract][Full Text] [Related]
2. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
Biggio G; Corda MG; Casu M; Gessa GL
Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
[No Abstract] [Full Text] [Related]
3. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
Biggio G; Costa E; Guidotti A
J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.
Di Chiara G; Porceddu ML; Spano PF; Gessa GL
Brain Res; 1977 Jul; 130(2):374-82. PubMed ID: 884534
[No Abstract] [Full Text] [Related]
5. Disappearance of cerebellar cyclic GMP induced by kainic acid.
Biggio G; Corda MG; Casu M; Salis M; Gessa GL
Brain Res; 1978 Oct; 154(1):203-8. PubMed ID: 212160
[No Abstract] [Full Text] [Related]
6. Different mechanisms mediating the decrease of cerebellar cGMP elicited by haloperidol and diazepam.
Biggio G; Costa E; Guidotti A
Adv Biochem Psychopharmacol; 1976; 15():325-35. PubMed ID: 192052
[No Abstract] [Full Text] [Related]
7. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
Zharkovskiĭ AM; Nurk AM
Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
[TBL] [Abstract][Full Text] [Related]
8. Receptor-linked cyclic AMP systems in rat neostriatum: differential localization revealed by kainic acid injection.
Minneman KP; Quik M; Emson PC
Brain Res; 1978 Aug; 151(3):507-21. PubMed ID: 27287
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cyclic GMP in cerebellum by a striatal dopaminergic mechanism.
Biggio G; Guidotti A
Nature; 1977 Jan; 265(5591):240-2. PubMed ID: 189208
[No Abstract] [Full Text] [Related]
10. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
Bannon MJ; Bunney EB; Zigun JR; Skirboll LR; Roth RH
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
[TBL] [Abstract][Full Text] [Related]
11. CCK modulation of cerebellar afferents: dopaminergic involvement.
Wood PL
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):513-8. PubMed ID: 2546180
[TBL] [Abstract][Full Text] [Related]
12. Climbing fiver activation and 3', 5'-cyclic guanosine monophosphate (cGMP) content in cortex and deep nuclei of cerebellum.
Biggio G; Guidotti A
Brain Res; 1976 May; 107(2):365-73. PubMed ID: 178409
[TBL] [Abstract][Full Text] [Related]
13. Intrastriatal injection of kainic acid prevents the development of postsynaptic dopamine receptor hypersensitivity after chronic haloperidol treatment.
Zarkovsky AM; Nurk AM; Rägo LK; Allikmets LH
Neuropharmacology; 1982 Feb; 21(2):155-8. PubMed ID: 7199630
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical interactions of competitive N-methyl-D-aspartate antagonists with dopaminergic neurotransmission and the cerebellar cyclic GMP system: functional evidence for a phasic glutamatergic control of the nigrostriatal dopaminergic pathway.
Rao TS; Cler JA; Mick SJ; Emmett MR; Farah JM; Contreras PC; Iyengar S; Wood PL
J Neurochem; 1991 Mar; 56(3):907-13. PubMed ID: 1847188
[TBL] [Abstract][Full Text] [Related]
15. Intranigral kainic acid: evidence for nigral non-dopaminergic neurons controlling posture and behavior in a manner opposite to the dopaminergic ones.
Olianas MC; De Montis GM; Concu A; Tagliamonte A; di Chiara G
Eur J Pharmacol; 1978 Jun; 49(3):223-32. PubMed ID: 566206
[TBL] [Abstract][Full Text] [Related]
16. Effect of morphine of prostaglandin E2 (PGE2)-sensitive adenylate cyclase in corpus striatum of rats and its cellular localization by using kainic acid.
Havemann U; Kuschinsky K
Brain Res; 1978 Jul; 150(2):441-5. PubMed ID: 209852
[No Abstract] [Full Text] [Related]
17. Decrease of [3H]5-HT high affinity binding and 5-HT adenylate cyclase activation after kainic acic lesion in rat brain striatum.
Fillion G; Beaudoin D; Rousselle JC; Deniau JM; Fillion MP; Dray F; Jacob J
J Neurochem; 1979 Aug; 33(2):567-70. PubMed ID: 224145
[No Abstract] [Full Text] [Related]
18. Loss of striatal dopaminergic receptors after intrastriatal kainic acid injection.
Fields JZ; Reisine TD; Yamamura HI
Life Sci; 1978 Aug; 23(6):569-73. PubMed ID: 692281
[No Abstract] [Full Text] [Related]
19. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
Breese GR; Mueller RA; Mailman RB
J Pharmacol Exp Ther; 1979 May; 209(2):262-70. PubMed ID: 35602
[No Abstract] [Full Text] [Related]
20. Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity.
Braszko JJ; Bannon MJ; Bunney BS; Roth RH
J Pharmacol Exp Ther; 1981 Feb; 216(2):289-93. PubMed ID: 6257886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
